highly significantp = 0.002
Nevertheless, an analysis restricted to the two sole studies testing the effect of paricalcitol on FMD in CKD patients showed a highly significant increase in FMD ( p = 0.002) by this drug.
Nevertheless, an analysis restricted to the two sole studies testing the effect of paricalcitol on FMD in CKD patients showed a highly significant increase in FMD ( p = 0.002) by this drug.